Posttranslational Modifications

Why This Matters

Posttranslational modifications (PTMs) represent the cell's toolkit for expanding the functional diversity of the proteome far beyond what the genome alone encodes. These chemical modifications rapidly and reversibly control protein activity, localization, stability, and interactions, all without synthesizing new proteins. Understanding PTMs means grasping core concepts like signal transduction, protein turnover, epigenetic regulation, and protein folding/stability.

Translation gives you a rough draft, but modifications create the final, functional product. Different PTMs achieve similar regulatory goals through distinct mechanisms. For exams, knowing which modification does what (and why) will help you predict cellular outcomes when specific pathways are disrupted. Don't just memorize the modifications; know what biological problem each one solves.

---

Reversible Covalent Switches: Rapid Signal Control

These modifications act as molecular on/off switches, allowing cells to respond to signals within seconds to minutes. The reversibility is what makes them so powerful: enzymes that add the modification are paired with enzymes that remove it, creating dynamic regulatory circuits.

Phosphorylation

• Phosphate group addition to Ser, Thr, or Tyr residues from ATP. This introduces two negative charges and steric bulk that alter protein conformation and activity.
• Kinases add, phosphatases remove. This enzyme pairing enables rapid, reversible signal switching in cascades like MAPK and PI3K/Akt.
• The most common PTM. Roughly 30% of proteins are phosphorylated at any given time, making phosphorylation central to nearly every signal transduction pathway you'll encounter.

Acetylation

• Acetyl group addition to lysine ε-amino groups. This neutralizes the positive charge of lysine, weakening electrostatic interactions between histones and the negatively charged DNA backbone.
• HATs add, HDACs remove. Histone acetyltransferases (HATs) and histone deacetylases (HDACs) dynamically regulate chromatin accessibility. The acetyl donor is acetyl-CoA.
• Generally activates transcription. Open chromatin (euchromatin) allows transcription factor binding. Acetylation also modifies non-histone proteins like p53 and tubulin, regulating their activity and stability.

Methylation

• Methyl groups added to Lys or Arg residues by methyltransferases using S-adenosylmethionine (SAM) as the methyl donor. Unlike acetylation, methylation does not change the residue's charge. Instead, it creates specific binding surfaces recognized by reader proteins containing chromodomains or Tudor domains.
• Context-dependent effects on gene expression. H3K4me3 is associated with transcriptional activation, while H3K9me3 and H3K27me3 are associated with repression. The residue modified, the degree of methylation (mono-, di-, or tri-), and the reader proteins recruited all determine the outcome.
• More stable than acetylation. Methylation marks can persist through cell division, contributing to epigenetic memory. Demethylases (e.g., LSD1, JMJD family) do exist, but turnover is slower than for acetylation.

---

Protein Tagging for Fate Determination

These modifications attach small proteins or protein-like molecules to targets, marking them for specific cellular fates. The "tag" itself carries information that other cellular machinery reads and acts upon.

Ubiquitination

Ubiquitin is a small 76-amino-acid protein attached to target lysine residues through a three-step enzyme cascade:

1. E1 (ubiquitin-activating enzyme) activates ubiquitin in an ATP-dependent reaction, forming a thioester bond.
2. E2 (ubiquitin-conjugating enzyme) accepts the activated ubiquitin from E1.
3. E3 (ubiquitin ligase) provides substrate specificity, catalyzing transfer of ubiquitin to the target protein's lysine residue via an isopeptide bond.

Polyubiquitin chains linked through K48 of ubiquitin are the canonical signal for proteasomal degradation. This is critical for cell cycle progression, where cyclins must be destroyed at precise times (e.g., APC/C is the E3 ligase that ubiquitinates mitotic cyclins).

Non-degradative roles also exist. Monoubiquitination regulates histone function and endocytic sorting, while K63-linked polyubiquitin chains participate in DNA repair and NF-κB signaling.

SUMOylation

• SUMO (Small Ubiquitin-like Modifier) proteins attached to lysine residues. The conjugation cascade parallels ubiquitination (E1, E2, E3) but uses distinct enzymes.
• Modulates localization and protein-protein interactions. SUMOylation often targets transcription factors and nuclear proteins, altering their activity or directing them to specific nuclear substructures like PML bodies.
• Stress response and genome stability. SUMOylation increases during cellular stress and plays roles in DNA damage repair pathways.

---

Irreversible Activation: Proteolytic Processing

Unlike reversible modifications, proteolytic cleavage permanently alters protein structure. This "one-way switch" ensures commitment to activation and prevents inappropriate reversal.

Proteolytic Cleavage

• Peptide bond hydrolysis activates zymogens. Inactive precursors (zymogens) like trypsinogen become active enzymes (trypsin) when a specific peptide segment is cleaved. The removal of this segment allows the active site to adopt its functional conformation.
• Cascade amplification. Blood clotting and complement pathways use sequential proteolysis where each activated protease cleaves and activates many copies of the next, amplifying the signal exponentially.
• Prevents premature activity. Digestive enzymes are synthesized as zymogens to protect the pancreas. Caspases are synthesized as procaspases to prevent accidental apoptosis. Activation occurs only when appropriate triggers arrive.

---

Structural Modifications: Stability and Folding

These PTMs directly influence protein architecture, ensuring proper folding and long-term stability. They're particularly important for secreted and extracellular proteins that must survive harsh environments outside the cell.

Disulfide Bond Formation

• Covalent $-S-S-$ bonds between cysteine residues. These cross-links stabilize tertiary and quaternary structure by covalently connecting regions of the polypeptide that may be far apart in primary sequence.
• Occurs in the ER for secreted proteins. The oxidizing environment of the ER lumen favors disulfide formation, while the reducing environment of the cytoplasm (maintained by glutathione and thioredoxin) keeps cytoplasmic cysteines reduced. Protein disulfide isomerase (PDI) catalyzes correct disulfide pairing in the ER.
• Critical for antibody function. Immunoglobulins rely on both intrachain and interchain disulfide bonds to maintain their characteristic Y-shaped structure and hold heavy and light chains together.

Hydroxylation

• Hydroxyl groups added to Pro and Lys residues by prolyl hydroxylase and lysyl hydroxylase. These enzymes require $\text{Fe}^{2+}$, $\alpha$-ketoglutarate, $\text{O}_2$, and vitamin C (ascorbate) as cofactors. Ascorbate keeps the iron in its reduced $\text{Fe}^{2+}$ state; without it, the enzyme becomes inactive.
• Essential for collagen triple helix stability. Hydroxyproline forms additional hydrogen bonds (via its hydroxyl group) that stabilize the collagen triple helix. Without hydroxylation, collagen denatures near body temperature.
• Oxygen sensing via HIF regulation. Prolyl hydroxylases hydroxylate HIF-1α under normoxic conditions, which creates a binding site for the von Hippel-Lindau (VHL) E3 ubiquitin ligase, targeting HIF-1α for proteasomal degradation. Under hypoxia, the hydroxylase cannot function (it needs $\text{O}_2$), so HIF-1α accumulates and activates genes for angiogenesis and glycolysis.

---

Localization Signals: Membrane Targeting

These modifications anchor proteins to membranes or direct them to specific cellular compartments. The lipid or carbohydrate addition provides a physical "address tag" that determines where a protein functions.

Lipidation

• Lipid groups attached to proteins increase hydrophobicity for membrane association. The three major types differ in their chemistry and reversibility:
  • Myristoylation: 14-carbon saturated fatty acid attached to an N-terminal glycine via an amide bond. Typically co-translational and irreversible.
  • Palmitoylation: 16-carbon saturated fatty acid attached to cysteine via a thioester bond. Reversible, allowing dynamic regulation of membrane association.
  • Prenylation (farnesylation/geranylgeranylation): Isoprenoid lipids attached to a C-terminal cysteine. Irreversible.
• Essential for signaling proteins. Farnesylation of Ras anchors it to the plasma membrane where it transduces growth signals. This is why farnesyltransferase inhibitors were explored as anti-cancer drugs.

Glycosylation

• Carbohydrate chains attached to Asn (N-linked) or Ser/Thr (O-linked). These modifications occur in the ER and Golgi during secretory pathway transit.
• N-linked glycosylation begins with a 14-sugar precursor ($\text{Glc}_3\text{Man}_9\text{GlcNAc}_2$) assembled on dolichol phosphate and transferred en bloc to the Asn residue within an Asn-X-Ser/Thr sequon (where X is any amino acid except Pro). Subsequent trimming in the ER and further modification in the Golgi create the mature glycoprotein.
• Functions include protein folding quality control, stability, and recognition. In the ER, the calnexin/calreticulin cycle uses glucose trimming on N-linked glycans to monitor folding status. On the cell surface, glycans mediate cell-cell interactions and immune recognition (ABO blood types are determined by specific glycosyltransferases that modify surface glycans).

---

Quick Reference Table

---

Self-Check Questions

1. Which two PTMs both regulate transcription through histone modification but have opposite default effects on chromatin accessibility?

2. A protein needs to be rapidly activated in response to a growth factor, then quickly inactivated when the signal stops. Which PTM is most likely involved, and why would proteolytic cleavage be inappropriate here?

3. Compare ubiquitination and SUMOylation: both attach small proteins to lysine residues, so how would you determine which modification a target protein has received based on its cellular fate?

4. A patient presents with symptoms of scurvy. Which PTM is disrupted, what enzyme requires the missing cofactor, and how does this explain the connective tissue problems observed?

5. FRQ-style: Explain how the same amino acid residue (lysine) can be modified by acetylation, methylation, ubiquitination, or SUMOylation. What determines which modification occurs, and what are the functional consequences of each?